Skip to main content

Table 3 Prognostic value of miRNA expression for the biochemical recurrence-free survival in univariate and multivariate analyses by Cox regression

From: Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients

  Hazard ratio(95% CI) P
Univariate   
 hsa-miR-188-5p 1.02(0.70 -1.48) 0.91
 hsa-miR-19a 0.85(0.35 -1.77) 0.66
 hsa-miR-193a-5p 0.60(0.35 -1.02) 0.06
 hsa-miR-374b 0.61(0.50 -0.75) 0.000**
 Gleason score 3.32(2.26-4.87) 0.000**
 Preoperative PSA 1.00(1.00-1.01) 0.013*
 Pathological tumor stage 3.85(1.59-9.32) 0.003**
 Age 1.04(0.98-1.09) 0.19
 Clinical stage group 0.85(0.39-1.89) 0.69
Multivariate   
 hsamiR374b 0.38(0.17 -0.85) 0.018*
 Gleason score 2.39(1.34-4.23) 0.003**
 Preoperative PSA 1.01(1.00-1.01) 0.022*
 Pathological tumor stage 2.17(0.64-7.37) 0.21
  1. * P < 0.05, ** P < 0.01.
\